BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26229233)

  • 1. Plasmodium falciparum parasitaemia among booked parturients who received two doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment in pregnancy (IPTp) in a tertiary health facility Southeast Nigeria.
    Nwali MI; Ejikeme BN; Agboeze JJ; Onyebuchi AK; Anozie BO
    Niger Med J; 2015; 56(3):218-24. PubMed ID: 26229233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
    Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria prevention practices and delivery outcome: a cross sectional study of pregnant women attending a tertiary hospital in northeastern Nigeria.
    Muhammad HU; Giwa FJ; Olayinka AT; Balogun SM; Ajayi I; Ajumobi O; Nguku P
    Malar J; 2016 Jun; 15():326. PubMed ID: 27315799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of asymptomatic malaria parasitaemia in neonates in a tertiary hospital, southeast Nigeria.
    Nwali MI; Umeora OU; Ozumba BC; Onoh RC; Agwu UM; Agboeze J
    Niger Med J; 2014 May; 55(3):250-3. PubMed ID: 25013259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria.
    Falade CO; Yusuf BO; Fadero FF; Mokuolu OA; Hamer DH; Salako LA
    Malar J; 2007 Jul; 6():88. PubMed ID: 17617910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
    Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
    Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi.
    Gutman J; Mwandama D; Wiegand RE; Abdallah J; Iriemenam NC; Shi YP; Mathanga DP; Skarbinski J
    Malar J; 2015 May; 14():197. PubMed ID: 25962439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
    Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
    Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
    Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
    Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.
    Mbonye AK; Birungi J; Yanow SK; Shokoples S; Malamba S; Alifrangis M; Magnussen P
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5475-82. PubMed ID: 26124154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study.
    Owusu R; Asante KP; Mahama E; Awini E; Anyorigiya T; Dosoo D; Amu A; Jakpa G; Ofei E; Segbaya S; Oduro AR; Gyapong M; Hodgson A; Bart-Plange C; Owusu-Agyei S
    PLoS One; 2015; 10(9):e0136828. PubMed ID: 26327623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique.
    Challis K; Osman NB; Cotiro M; Nordahl G; Dgedge M; Bergström S
    Trop Med Int Health; 2004 Oct; 9(10):1066-73. PubMed ID: 15482398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on the prevalence of malaria parasitaemia in pregnancy.
    Umeh UA; Obi SN; Onah HE; Ugwu EO; Ajah LO; Umeh CR; Okafor II
    Trop Doct; 2012 Jul; 42(3):133-5. PubMed ID: 22399105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.
    Braun V; Rempis E; Schnack A; Decker S; Rubaihayo J; Tumwesigye NM; Theuring S; Harms G; Busingye P; Mockenhaupt FP
    Malar J; 2015 Sep; 14():372. PubMed ID: 26410081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.
    Toure OA; Kone PL; Coulibaly MA; Ako BA; Gbessi EA; Coulibaly B; N' Guessan LT; Koffi D; Beourou S; Soumahoro A; Bassinka I; Nogbou M; Swa T; Gba B; Esmel B; Bokossa EM
    Parasit Vectors; 2014 Nov; 7():495. PubMed ID: 25410760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of asymptomatic maternal malaria parasitaemia at parturition on perinatal outcome.
    Sule-Odu AO; Ogunledun A; Olatunji AO
    J Obstet Gynaecol; 2002 Jan; 22(1):25-8. PubMed ID: 12521723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.
    Olliaro PL; Delenne H; Cisse M; Badiane M; Olliaro A; Vaillant M; Brasseur P
    Malar J; 2008 Nov; 7():234. PubMed ID: 18992140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC).
    Likwela JL; D'Alessandro U; Lokwa BL; Meuris S; Dramaix MW
    Trop Med Int Health; 2012 Mar; 17(3):322-9. PubMed ID: 22212628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania.
    Tarimo SD
    East Afr J Public Health; 2007 Oct; 4(2):80-3. PubMed ID: 18085136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.